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Abstract
Background: Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity.
Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to induce strong
CD4+ and CD8+ T-cell mediated immune responses in the absence of excessive inflammation as observed with other Gram-
negative bacteria. However, some Brucella strains interfere with the maturation of dendritic cells (DCs), which is essential for
antigen-specific T-cell priming. In the present study, we investigated the interaction of human monocyte-derived DCs with
the smooth attenuated B. abortus strain (S) 19, which has previously been employed successfully to vaccinate cattle.
Methodology/Principal findings: We first looked into the potential of S19 to hamper the cytokine-induced maturation of
DCs; however, infected cells expressed CD25, CD40, CD80, and CD86 to a comparable extent as uninfected, cytokine-
matured DCs. Furthermore, S19 activated DCs in the absence of exogeneous stimuli, enhanced the expression of HLA-ABC
and HLA-DR, and was able to persist intracellularly without causing cytotoxicity. Thus, DCs provide a cellular niche for
persisting brucellae in vivo as a permanent source of antigen. S19-infected DCs produced IL-12/23p40, IL-12p70, and IL-10,
but not IL-23. While heat-killed bacteria also activated DCs, soluble mediators were not involved in S19-induced activation
of human DCs. HEK 293 transfectants revealed cellular activation by S19 primarily through engagement of Toll-like receptor
(TLR)2.
Conclusions/Significance: Thus, as an immunological prerequisite for vaccine efficacy, B. abortus S19 potently infects and
potently activates (most likely via TLR2) human DCs to produce Th1-promoting cytokines.
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Introduction
Novel vaccine strategies for the induction of cellular immune
responses are based on the use of suitable microbial shuttles, which
include the genetic information encoding immunogenic epitopes
of the targeted pathogen. Besides various viral vectors, such as
adenoviruses or poxviruses [1], certain bacterial vaccine strains
have been engineered successfully. For instance, strains of the
attenuated Salmonella enterica serovar Typhi with antigens derived
from pathogens, such as Helicobacter pylori, Plasmodium falciparum, or
Hepatitis B virus, have already been tested in volunteers. Thus far,
only a minority of the vaccines, however, was successful in
inducing substantial cellular or humoral immune responses [2].
Brucella abortus is a Gram-negative alpha-proteobacterium and
the cause of bovine brucellosis. Since the lipopolysaccharide (LPS)
of brucellae is less pyrogenic than enterobacterial LPS, brucellae
may be advantageous as vaccine vectors [3]. Both Th1 CD4+ and
CD8+ T cell subsets are activated during the course of
experimental infection [4,5]. Antigenic preparations of brucellae,
such as heat-inactivated bacteria or DNA, have been used as
adjuvants for the induction of systemic and mucosal Th1 immune
responses in mice [6–10] and non-human primates [11].
Two attenuated B. abortus strains have been developed to control
bovine brucellosis, i.e., the smooth strain (S)19 and the rough one,
RB51[12]. Both strains induce potent cellular immune responses
in mice [5,13–15], and have been used to develop live or
replication-incompetent vectors for exogenous antigens [16,17].
Recombinant strain RB51 expressing the antigens of Neospora
caninum, MIC1 and GRA6, for instance, induces protective
immune responses against a lethal murine N. caninum infection
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[18]. Notably, rough brucellae have been shown to induce higher
amounts of various cytokines and chemokines in human mono-
cytes in vitro than smooth strains [19]. Therefore, recombinant
vectors differing in phenotypical characteristics, such as their type
of LPS, may also differ with respect to the immune responses
induced in vivo.
Although clinical manifestations of accidental infections with
S19 in humans were mild [20], and a related strain, S19-BA, has
been used in the former USSR as a vaccine in humans [21], the
safety profile of the present S19 (without further attenuation) is not
adequate for its use in humans [21].
Essential for the use of brucellae as vectors for the induction of
cellular immune responses is their interaction with antigen-
presenting cells. Activation of monocytes [22,23], macrophages
[23], as well as neutrophils [24] by brucellae has been reported.
Notably, different Brucella spp. including a GFP-expressing mutant
of the virulent B. abortus strain 2308 can also readily infect
dendritic cells (DCs) [25]. As DCs, which are matured as a
consequence of cellular activation, are the most potent antigen-
presenting cells for the priming of naı̈ve T cells and thereby
induction of cellular immune responses, this cell type is of
particular interest in vaccine immunology [26]. In mice, DCs are
the major source of IL-12 when heat-killed brucellae are used as
an adjuvant [9]. Zwerdling et al. [27] have demonstrated that the
virulent smooth B. abortus strain, 2308, also activates human DCs
leading to the secretion of cytokines, e.g., IL-12p40 and IL-10, and
that Brucella-derived lipoproteins represent the inflammatory
principle of brucellae. However, the study did not address whether
the bacteria themselves were sufficient for the induction of DC-
activation or whether an autocrine cytokine-mediated effect
further matured the cells. Furthermore, it has not been further
differentiated whether the IL-12p40 measured was paired to either
p35 or p19 thereby composing IL-12p70 or IL-23, respectively,
which is of relevance for the T-cell response induced [28].
In contrast to the potential of brucellae to activate DCs, B. suis
has been reported to prevent human DC-maturation due to the
Figure 1. B. abortus S19 does not interfere with the cytokine-induced maturation of immature human DCs. Monocyte-derived immature
DCs were infected with B. abortus S19 (MOI, 20) for 1 h, the bacteria were washed out, and the cells incubated in the presence of pro-inflammatory
cytokines (TNF-a, IL-1b, IL-6, PGE2). Uninfected control cells were incubated alongside in the presence or absence of cytokines. (A) After 48 h, the
phenotype of the cells was determined by flow cytometry (bold lines, stimulated cells; grey areas, unstimulated cells; dotted lines, isotype controls).
One representative of at least six independent experiments is shown. (B) Supernatants were analyzed for the presence of IL-12/23p40, IL-12p70, IL-23,
and IL-10 (data expressed as median with interquartile range; n.s., not significant).
doi:10.1371/journal.pone.0065934.g001
Brucella Abortus S19 Activates Human DCs
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e65934
failure of the cells to produce TNF-a [29]. Likewise, B. abortus
affects the maturation of murine DCs, and this effect has been
attributed to the Brucella protein, Btb1, which interferes with the
Toll-like receptor (TLR)2 signaling pathway [30].
As the strong T-cell stimulating potential of the smooth
attenuated B. abortus S19 in vivo has been documented before
[13,15], we were interested in the possible underlying mechanisms.
In the present study, we investigated the effects of S19 on the
cytokine-induced maturation of monocyte-derived DCs as well as
on immature DCs. We show that S19 does not interfere with but
modulates the cytokine-induced DC-maturation. Furthermore,
S19 potently activates immature DCs most likely through TLR2/
TLR6, persists intracellularly without causing excessive cytotox-
icity, and induces the secretion of IL-12p70 identifying it as a
potential source for the future development of a bacterial vector
for vaccine antigens requiring Th1 responses.
Materials and Methods
Bacteria
B. abortus S19 was kept virulent by mouse passages. Cultures
obtained from spleen homogenates were grown in tryptic soy
broth, harvested in log phase, dispensed in 0.5 ml aliquots, and
frozen at –70uC until needed [15]. For experiments using heat-
inactivated S19, bacteria were inactivated by incubation at 70uC
for 30 min or 20 h. B abortus 2308 was grown similarly and
inactivated by incubation at 70uC for 20 h. Inactivation was
verified by the lack of bacterial growth in tryptic soy broth. All
procedures involving live B. abortus 2308 were performed under
BSL-3 conditions. Inactivated bacteria were stored at 260 to
280uC until use.
Generation of human DCs
Buffy coats (German Red Cross, Berlin) or peripheral blood
from healthy volunteers (obtained from lab members who gave
their verbal informed consent, documented in lab notebooks, and
approved by the ethics committee of the Charité, 119 EA1/316/
12) were used to isolate PBMCs. Monocyte-derived DCs were
Figure 2. Human immature DCs are activated by B. abortus S19. Monocyte-derived immature DCs were infected with B. abortus S19 (MOI, 20)
for 1 h, the bacteria were washed out, and the cells were incubated for another 48 h. Control cells were left uninfected. (A) After 48 h, the phenotype
of the cells was determined by flow cytometry (bold lines, infected cells; grey areas, uninfected cells; dotted lines, isotype controls). One
representative of at least six independent experiments is shown. (B) Supernatants were analyzed for the presence of IL-12/23p40, IL-12p70, IL-10, and
TNF-a. Data expressed as median with interquartile range.
doi:10.1371/journal.pone.0065934.g002
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generated from magnetically separated CD14+ monocytes (Milte-
nyi Biotec, Bergisch-Gladbach, Germany) as previously described
[31]. Briefly, monocytes were cultured at 36106 cells/well in 6
well cell culture dishes (Nunc, Roskilde, Denmark; or TPP,
Trasadingen, Switzerland) for 6 days in RPMI 1640, supplement-
ed with 2 mM L-glutamine, 50 mM 2-mercaptoethanol, 10 mM
HEPES (all GIBCO, Invitrogen, Karlsruhe, Germany), recombi-
nant human GM-CSF (1000 U/ml, sargramostim, LeukineH,
Berlex, Richmond, CA), recombinant human IL-4 (100 U/ml,
R&D Systems, Wiesbaden-Nordenstadt, Germany), and 10%
heat-inactivated FCS (Biochrom, Berlin, Germany), adding fresh
medium and cytokines every other day. In some experiments, cells
were matured by recombinant human IL-6, tumor necrosis factor
alpha (TNF-a), IL-1b (all 10 ng/ml, R&D Systems) and 10 mM
PGE2 (Sigma, Taufkirchen, Germany) [31,32].
Infection of DCs with B. abortus S19
DCs were incubated with B. abortus S19 at MOI 20 in antibiotic-
free medium for 60 min at 37uC and 5% CO2. To remove
extracellular bacteria, cell cultures were washed five times with
medium followed by incubation in the presence of gentamicin (100
mg/ml; Biochrom) for 90 min at 37uC and 5% CO2. Cells were
washed another three times in medium, applied to the individual
experiments, and gentamicin (10 mg/ml) was added to the cultures
to sustain the control of the bacteria.
To determine numbers of intracellular bacteria, cells were
washed to remove the gentamicin, counted, and lysed in 0.2%
Triton-X-100/PBS for 30 min at 37Cu and 5% CO2 [33].
Suspensions were spread in serial dilutions on tryptic soy agar or
Columbia agar, and colonies were counted after 5 d incubation at
37uC and 5% CO2.
Flow cytometry
The phenotype of human DCs was monitored by flow
cytometry with PE- or FITC labeled anti-human mAbs to the
following surface molecules: HLA-DR, CD14, CD25, CD80,
CD86 (all BD Pharmingen), CD83 (Caltag Laboratories, Ham-
burg, Germany), HLA-ABC (Dako; BIOZOL Diagnostica,
Eching, Germany), or the appropriate isotype controls, as
previously described [31]. For detection of intracellular antigens,
cells were fixed for 30 min in 4% paraformaldehyde/PBS (w/v),
permeabilized by washing twice in 0.5% saponin (Sigma), and
subsequently stained with rabbit anti-Brucella-LPS serum (BD) for
60 min in 0.5% saponin, followed by incubation with a secondary
FITC-conjugated goat anti-rabbit IgG mAb (Jackson) for another
60 min in 0.5% saponin. All cell populations were fixed with 10%
formaldehyde/PBS (v/v) before analysis on a FACSCaliburH
cytometer with CELLQuestHPro software (BD Biosciences).
Analysis of cytokine secretion by DCs
48 h cell-free supernatants of DC cultures were harvested and
stored at –80uC until analysis by sandwich ELISAs for IL-12/
23p40, IL-12p70, IL-10, TNF-a (all U-CyTech, Utrecht, The
Netherlands), or IL-23 (eBioscience).
Analysis of the involvement of TLRs in the cellular
recognition of B. abortus S19 or B. abortus 2308
To investigate the involvement of different TLRs in immune
cell stimulation by B. abortus S19 and strain 2308, the human
embryonal kidney cell line HEK 293 was employed as described
previously [34]. In brief, cells were cultured in DMEM medium
(Gibco) including sodium pyruvate supplemented with 10% fetal
bovine serum, 10 kU/ml penicillin, 10 g/ml streptomycin, and
200 mM L-glutamine. For stimulation experiments, cells were
cultured at a density of 16105 cells/well in 12-well tissue culture
plates over night. Transfection with expression plasmids encoding
ß-galactosidase (0.04 mg) and the ELAM NF-kB luciferase reporter
plasmid (0.12 mg, both kindly provided by C. J. Kirschning, Essen,
Germany) for 24 h was performed employing 0.5 ml/well FugeneH
(Roche, Mannheim, Germany). Cells were additionally transfected
with hTLR-2, and in addition hTLR1 or TLR6, or with hTLR4
and MD-2 as indicated. Cells were stimulated for 20 h with
inactivated brucellae, the lipopeptide Pam2Cys (InvivoGen, San
Diego, CA, USA), or LPS (from S. enterica Minnesota Re595,
Sigma; or from Escherichia coli EH100, Alexis Biochemicals, Enzo
Life Sciences, Lörrach, Germany), as indicated in 0.5 ml DMEM
medium without FCS, followed by lysis and measurement of ß-
galactosidase and luciferase activity employing a kit based on
chemiluminescence (Roche, Mannheim, Germany). Chemilumi-
nescence values were normalized for transfection efficacy indicated
by ß-gal values and given as relative light units (RLU).
Experiments were performed in triplicates and repeated once. In
addition, IL-8 concentrations in supernatant were determined by
using a paired IL-8 mAb sandwich ELISA (BD Biosciences).
Statistics
Statistical significance of differences was determined by the
Wilcoxon matched-pairs signed rank test (data expressed as
median with interquartile range) or the paired Student’s t test
(data expressed as mean 6 standard deviation) using GraphPad
Prism version 6.0a for Mac OS X. Differences were considered
statistically significant for p,0.05.
Results
B. abortus S19 does not interfere with the maturation of
human DCs but alters their cytokine-secretion pattern
It has recently been shown that B. suis and B. abortus may
prevent the maturation process of DCs [29,30]. To investigate
whether B. abortus S19 similarly inhibits DC-maturation, we
infected immature human DCs (MOI, 20) for 1 h, washed the
cells, added antibiotics, and cultured the cells in the presence of
pro-inflammatory cytokines, which lead to the maturation of DCs
and may as well be produced in the course of human brucellosis
[31,32]. Uninfected control cells also were incubated in the
presence of cytokines or kept immature by culturing in the absence
of additional cytokines. After 48 h, we harvested the cells and
monitored the expression of DC maturation markers by flow
cytometry. Upon co-culture in the presence of cytokines, both
infected and uninfected DCs showed up-regulated surface
expression of markers typically expressed by mature DCs whereas
the uninfected control cells cultured in the absence of cytokines
were negative for CD25 and expressed considerably less CD40,
CD80, CD83, and CD86 than cytokine-matured cells (Figure 1A).
CD25, CD80, CD83, and CD86 were significantly higher
expressed by cytokine-incubated, uninfected or infected DCs than
by control cells incubated in medium alone while infected and
uninfected, cytokine-incubated DCs did not differ regarding the
expression of these molecules (Figure S1). The viability of infected
and uninfected DCs was comparable (infected, 76.86% +/2
19.09%; uninfected, 84.86% +/2 11.61%; n = 7; p = 0.210).
Thus, B. abortus S19 does not interfere with the differentiation of
human DCs upon maturation by pro-inflammatory cytokines nor
does it show cytotoxic effects.
Since mature DCs produce cytokines involved in T-cell
activation and differentiation, we were interested whether the
infection with S19 might inhibit the cytokine production or alter
Brucella Abortus S19 Activates Human DCs
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the cytokine profile of activated DCs. We therefore analyzed the
concentrations of IL-12/23p40, IL-23, IL-12p70, and IL-10 in the
supernatants collected 48 h after adding the cytokines to freshly
infected or uninfected DCs. We detected similar concentrations of
IL-12/23p40 and IL-23 in supernatants from infected and
uninfected cells (Figure 1B). However, secretion of both the
Th1-driving cytokine, IL-12p70, and the anti-inflammatory
cytokine, IL-10, was significantly enhanced in cytokine-matured
and infected DCs as compared to uninfected cells. Uninfected,
immature control cells kept in medium did not produce substantial
amounts of any of these cytokines. Therefore, infection of DCs
with B. abortus S19 does not inhibit but modifies the maturation-
induced secretion of cytokines, i.e., it significantly enhances the
secretion of IL-12p70 and IL-10.
B. abortus S19 activates immature human DCs
To further analyze the increased production of IL-12p70 and
IL-10 by infected DCs (Figure 1B), we infected immature DCs
with B. abortus S19 in the absence of additional cytokines and
analyzed the phenotype of the cells 48 h later. Immature cells were
kept uninfected as control.
Infected DCs expressed CD25, CD40, CD80, and CD86
significantly higher on their surface than control cells (Figure 2A,
Figure S2). Although statistically not significant, there also was a
strong trend (p = 0.06) for a higher expression of CD83 following
exposure of the cells to B. abortus S19. Notably, infected and
uninfected DCs did not differ regarding their viability (infected,
74% +/2 28.23%; uninfected, 70.71% +/2 30.18%; n = 7;
p = 0.898). Correlating with the phenotypic pattern of activated
cells, infected DCs secreted substantial amounts of IL-12/IL-
23p40, which was partially produced as IL-12p70 (Figure 2B),
whereas IL-23 was not detected in supernatants from infected nor
uninfected DCs (data not shown). Furthermore, infected DCs but
not uninfected control cells also produced IL-10 and TNF-a.
Therefore, S19 potently activates human DCs to produce mainly
Th1-promoting cytokines, which is in line with the strong T-cell
inducing effect of B. abortus S19 in vivo [13,15].
B. abortus S19 induces higher expression of HLA-ABC and
HLA-DR on human DCs in the absence of pro-
inflammatory cytokines
Since high expression of MHC molecules is required for
efficient antigen presentation by DCs, we next determined
whether B. abortus S19 alters the expression of these molecules
on monocyte-derived DCs. Immature DCs were infected with S19
while control cells were kept uninfected. The bacteria were washed
out and cells were incubated in the presence or absence of pro-
inflammatory cytokines as before. Two days later, HLA-ABC and
HLA-DR expression was analyzed by flow cytometry. Infected
cells incubated in the absence of cytokines expressed both HLA-
ABC and HLA-DR at higher levels than uninfected controls cells
(Figure 3). In contrast, there was no difference between infected
and uninfected cells incubated in the presence of cytokines
regarding HLA-ABC (p = 0.6) or HLA-DR (p = 0.3). Thus,
infection with S19 increases MHC expression on human DCs in
the absence of cytokine stimulation while it does not further
enhance the expression of these molecules on cytokine-matured
cells.
Pro-inflammatory cytokines limit the persistence of B.
abortus S19 in DCs
Since B. abortus S19 invaded DCs without apparent cytotoxic
effects, we were interested in whether the bacteria may persist in
DCs and in monitoring the cellular differentiation state over time.
We therefore cultured infected cells in the presence or absence of
cytokines, harvested cells at days 0, 2, 6, and 10, and determined
their maturation state by flow cytometry as well as the intracellular
CFUs after lysis of the cells. B. abortus S19 survived in cytokine-
incubated DCs for at least 6 days. At day 10, we detected viable
bacteria at low CFU in only one out of three experiments. In
contrast, in the absence of pro-inflammatory cytokines, bacteria
persisted over the entire observation period, and at d 10,
significantly more bacteria could be cultured from these DCs
than from cells incubated in the presence of cytokines (Figure 4;
p = 0.034, paired Student’s t test). The morphology of the bacterial
colonies was smooth in all experiments, i.e., we did not observe
any phenotypic change of S19 towards a rough colony type. Thus,
when B. abortus S19 invades DCs that are cultured in the presence
of pro-inflammatory cytokines, numbers of intracellular bacteria
decline over time. In contrast, after infection of immature DCs, the
bacteria can persist for at least 10 days despite concurrent cellular
activation, and such cells might provide a cellular niche for the
bacterial persistence and a source of T-cell stimulating brucella
antigens in vivo.
To identify Brucella-positive cells within DC populations, we
applied intracellular staining for the detection of brucella-positive
cells by using antibodies against Brucella-LPS in combination with
mAbs binding to surface molecules typically expressed by mature
DCs. Simultaneous staining of infected cells for both maturation
markers and Brucella LPS revealed that the majority of CD25-
positive DCs at day 2 also contained Brucella (or LPS thereof). At
later time points, however, LPS-positive DCs became negative for
CD25 in a time-dependent manner. This was particularly
pronounced in DCs incubated in the presence of cytokines where
most of the LPS-positive cells did not express CD25 at days 6 and
10 post infection (Figure 5). Therefore, B. abortus S19 might survive
better in less mature than in fully mature DCs. Alternatively,
infected cells might down-regulate certain DC maturation
markers.
Brucella-induced DC-activation is due to the direct
interaction of the cells with the bacteria and not due to
soluble mediators
To investigate whether Brucella-infected cells may secrete
cytokines that induce a bystander-maturation of uninfected cells,
or alternatively, that brucellae produce a soluble DC-maturing
factor, we collected supernatants from DCs 48 h post infection,
incubated immature DCs for 48 h in the presence of these
supernatants or supernatants from uninfected cells, and deter-
mined the phenotype by flow cytometry. Further controls included
uninfected, immature DCs incubated in the presence of pro-
inflammatory cytokines and cells kept in medium with GM-CSF
and IL-4 at an immature state. DCs exposed to supernatants from
S19-infected DCs and cells exposed to supernatants from
uninfected DCs did not differ considerably regarding their
phenotype, i.e., both populations expressed CD25, CD83, and
CD86 at substantially lower levels than DCs incubated in the
presence of cytokines (Figure 6). These data suggested that the
amounts of TNF-a (and possibly other pro-inflammatory cyto-
kines, such as IL-1b or IL-6) produced by Brucella-infected DCs
were not sufficient for the induction of phenotypic maturation of
accompanying, uninfected cells. To verify this finding, we
incubated immature DCs in medium supplemented with concen-
trations of recombinant TNF-a comparable to those found in
supernatants of infected cells (200 pg/ml). However, this treat-
ment neither led to phenotypically matured DCs (data not shown).
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To further analyze the underlying mechanism of B. abortus S19-
induced DC-activation, we incubated immature DCs with heat-
inactivated S19. Phagocytosed bacteria were readily detected
using the antibody to brucella LPS 4 h later (data not shown). At
48 h, Brucella-treated cells expressed a matured phenotype, i.e.,
most of the cells expressed CD25 and CD83, and the entire
population stained positive for CD40, CD80, and CD86 (Figure 7).
CD25, CD80, CD83, and CD86 were significantly higher
expressed by Brucella-treated DCs than by control cells (Figure S3).
These data demonstrate that the activation of immature human
DCs by B. abortus S19 most likely depends on the interaction of
cellular pattern-recognition receptors with bacterial antigens.
B. abortus S19 is mainly recognized by TLR2
In order to identify the pattern-recognition-receptor pathway
involved in DC-activation by B. abortus S19 observed before, we
studied TLRs as putative receptors. Data regarding the recogni-
tion of brucellae through TLRs are ambiguous and both TLR2
and TLR4 have been reported to be involved depending on the
bacterial species and strains as well as on the experimental
conditions used [35]. In order to extend these results to S19, we
employed a TLR overexpression system based on the human
embryonal kidney cell line HEK293 that is usually unresponsive to
bacterial stimuli [34], and analyzed TLR4/MD2, TLR2/TLR1,
and TLR2/TLR6 heterodimers. Although B. abortus DNA is
recognized by TLR9, and IL-12p40 secretion of murine splenic
DCs or macrophages in vitro depends on TLR9 [36,37], we did
not include TLR9 in our experimental setup since it is expressed
by murine but not by human myeloid antigen-presenting cells
including DCs [38,39].
When HEK293 cells were transfected with the LPS receptor
consisting of TLR4 and MD-2, heat-inactivated S19 failed to
induce a strong NF-kB activation as indicated by a reporter gene
assay. Although at high concentrations faint NF-kB activation was
observed, it was significantly weaker than LPS-mediated stimula-
tion (Figure 8A). Furthermore, the cells completely failed to release
IL-8 in response to B. abortus S19 further indicating that the
bacteria are not recognized by TLR4 (Figure 8B). In contrast, both
NF-kB activation and IL-8-release was induced by heat-inactivat-
ed bacteria in a dose-dependent manner in HEK293 cells
overexpressing TLR2, which was comparable to the dose-
dependent activation by a classical lipopeptide TLR2 ligand
(Fig. 9). Additional transfection of TLR1 or TLR6 failed to further
increase the response (data not shown). While this largely rules out
an involvement of TLR1, the negative results obtained with the
overexpression of TLR6 may be caused by the fact that HEK293
cells constitutively express TLR6 but not TLR1.
Since these data for S19 were contradictory to those reported
previously by Zwerdling et al. for heat-inactivated wild-type B.
abortus 2308 [27], we compared these two B. abortus strains
alongside in the same TLR overexpression system as before. We
also included a smooth LPS (derived from E. coli EH100) as
control stimulus to verify that our experimental system recognizes
smooth LPS preparations. Notably, both B. abortus strains activated
Figure 3. Increased MHC expression by strain S19-infected DCs. Immature DCs were infected with B. abortus S19 at MOI 20, the bacteria were
washed out, antibiotics were added, and the cells were then incubated in the presence or absence or pro-inflammatory cytokines. After 42 h, the
cellular expression of HLA-ABC (A) or HLA-DR (B) was determined by flow cytometry. Medians of the MFIs as well as the 25% and 75% percentiles of
the MFIs for cells from eight donors (MFIs for isotype controls did not exceed 3.5). * p,0.05 compared to untreated DCs (Wilcoxon matched-pairs
signed rank test).
doi:10.1371/journal.pone.0065934.g003
Figure 4. Prolonged intracellular survival of B. abortus S19 in
unstimulated DCs compared with cytokine-matured DCs.
Immature DCs were infected with B. abortus S19 at MOI 20, the
bacteria were washed out, antibiotics were added, and the cells were
then incubated in the presence or absence or pro-inflammatory
cytokines. Cells were lysed at day 0 to determine the initial number
of intracellular bacteria, and on days 2, 6, and 10 to ascertain the
intracellular bacterial numbers over time. CFUs differed significantly at
d10 (*, p,0.05).
doi:10.1371/journal.pone.0065934.g004
Brucella Abortus S19 Activates Human DCs
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e65934
and induced IL-8 secretion in TLR2-expressing HEK293 cells in a
comparable manner. In contrast, both B. abortus strains failed to
induce IL-8 secretion in TLR4-expressing cells, which, however,
were activated by two different LPS preparations (rough, LPS
Re595; smooth, LPS EH100) and secreted IL-8 (Figure 10).
Similar data were obtained in the reporter gene assay for
intracellular NF-kB activation through B. abortus S19 and strain
2308 (data not shown). Thus, in the TLR overexpression system
used, both B. abortus S19 and strain 2308 are primarily recognized
through TLR2, most likely in form of the TLR2/6 heterodimer,
but not TLR4. The lack of recognition by TLR4 cannot be
explained by a general unresponsiveness of the transfected cells to
TLR4 ligands since both LPS preparations, i.e., rough Salmonella
LPS and smooth LPS derived from E. coli, were recognized by this
system.
Discussion
Microbial vectors are attractive for vaccine strategies aiming at
the induction of strong cellular immune responses, and a large
number of shuttles have been engineered from both viral and
bacterial origin. The attenuated B. abortus S19 might comprise an
advantageous bacterial vector since brucellae are much less
pyrogenic than other enterobacteriae but has been shown to
induce robust CD4+ and CD8+ T-cell responses in vivo [13,15]. In
the present study, we elucidated the interaction of B. abortus S19
with human DCs since their functions are crucial for the induction
of immune responses against brucellae and thereby also against
potential inserted foreign antigens.
First we investigated whether B. abortus S19 might hamper the
maturation of human DCs. This has been shown previously for B.
suis [29]. S19 altered the cytokine secretion profile in infected cells,
i.e., infected DCs produced IL-12p70 while uninfected cytokine-
matured DCs produced IL-12p40 but not IL-12p70, which is in
agreement with previous observations [40]. In contrast to B. suis,
B. abortus S19, did not interfere with DC-maturation although at
later time points after infection the bacteria persisted in less mature
cells. In contrast, S19 potently activated human DCs in the
absence of other maturation stimuli. This was evident by enhanced
surface expression of CD86, HLA-ABC, and HLA-DR, and a
substantial increase in CD25, CD80, and CD83 expression,
typical for mature DCs [26]. Activation of human DCs has also
been observed for the virulent B. abortus strain 2308, which
induced a comparable phenotype in monocyte-derived DCs as
shown for S19 by us [27]. Since both DC-activating strains S19
and 2308 are smooth strains of B. abortus, the phenomenon of the
bacterial interference with DC-maturation is not essentially
associated with the presence of smooth LPS as suggested
previously [41]. Zwerdling et al. [27] also observed secretion of
IL-12p40 by 2308-activated DCs. Since p40 is a subunit shared by
IL-12p70 and IL-23, we further characterized the cytokines and
detected only IL-12p70 but not IL-23. Notably, infected DCs
simultaneously produced the anti-inflammatory cytokine IL-10,
independent of the presence of cytokines as further maturation
stimulus. This simultaneous secretion of IL-10 and pro-inflamma-
tory cytokines might control the duration and degree of the
brucellae-induced inflammatory response.
Survival of brucellae for 48 h in human DCs has been
documented before [25]. Here, we show that S19 is able to persist
in DCs even for at least ten days without cytotoxic effects. Notably,
the bacteria survived better in not fully mature than in mature
cells. This was also true for DCs that received a maturation
Figure 5. B. abortus strain S19 persists in less mature cells in both medium-incubated and cytokine-matured DCs. Immature DCs were
infected with B. abortus S19 at MOI 20, the bacteria were washed out, antibiotics were added, and the cells were incubated in the presence or
absence or pro-inflammatory cytokines. At days 2, 6, and 10, cells was harvested and analyzed by flow cytometry for their extracellular expression of
CD25 and the intracellular content of Brucella-LPS. One representative experiment of three independent experiments is shown.
doi:10.1371/journal.pone.0065934.g005
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stimulus through cytokines. Future studies should address whether
this survival also depends on the interaction of the virB type IV
secretion system of the bacteria with the endoplasmic reticulum, as
it has previously been shown for murine bone marrow-derived
macrophages [42]. VirB proteins are expressed by S19 under
acidic conditions, but less than by wild-type B. abortus at neutral
pH [43].
The activating effect of S19 on DCs could not be transferred
with supernatants from infected cells to uninfected DCs. Thus,
cytokines, e.g., TNF-a that contributes to canarypox virus-induced
maturation of human DCs [44], are not involved in the S19-
induced DC-activation. Likewise, viable bacteria were not
required for this process since heat-killed brucellae were equally
able to induce DC-activation.
Figure 6. Failure of supernatants from B. abortus S19-infected
DCs to transfer the DC-activating potential to immature,
uninfected DCs. Immature cells were infected with B. abortus S19
(MOI, 20) or left uninfected and cultured for 48 h. Supernatants were
harvested and transferred (50% vol/vol) to uninfected, immature DCs,
and the phenotype of the cells was determined after 48 h. The
expression of typical DC-maturation markers vs. size (FSC) is shown.
One representative experiment of three independent experiments with
comparable results is shown.
doi:10.1371/journal.pone.0065934.g006
Figure 7. Inactivated B. abortus S19 activates monocyte-derived DCs. Immature DCs were incubated in the presence of heat-inactivated B.
abortus S19 (equivalent to MOI 10) or kept in GM-CSF and IL-4 as immature cells. After 48 h, the phenotype of the cells was characterized by flow
cytometry. One representative experiment of six independent experiments with comparable results is shown.
doi:10.1371/journal.pone.0065934.g007
Figure 8. B. abortus S19 largely fails to induce NF-kB activation
in HEK293 cells overexpressing TLR4 and MD-2. HEK293 cells
were transiently transfected with human TLR4 and MD-2. After
stimulation with LPS or heat-inactivated B. abortus S19, NF-kB activation
was assessed by a reporter gene assay (A), and IL-8 release by ELISA (B).
Cells not transfected with TLR4 and MD-2 did not exhibit NF-kB-
activation (not shown). Measurements were performed in triplicates,
shown are mean values 6 SD. One representative experiment out of
two is shown.
doi:10.1371/journal.pone.0065934.g008
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These results suggested that DC-activation induced by B. abortus
S19 probably depends on heat-stable bacterial components
recognized by pattern-recognition receptors, such as TLRs. We
therefore investigated the involvement of TLR2 in combination
with TLR1 or TLR6 and TLR4 in bacterial recognition and
found that S19 activates cells primarily via TLR2 in combination
with TLR6 but neither TLR4 nor TLR1. Similar data were
obtained with heat-inactivated B. abortus 2308. Notably, TLR2 but
not TLR4 engagement on DCs during immune priming is
associated with a strong CD4+ memory T-cell response [45].
Possible bacterial ligands are the lipidated forms of Omp16 or
Omp19, which in addition to heat-inactivated brucellae have been
shown to induce TNF-a and IL-6 production by the human
monocytic cell line, THP-1, in a TLR2-dependent manner [46].
TLR2-dependent IL-6 secretion is also involved in down-
regulation of MHC-II molecules and of the antigen processing
capacity of THP-1 cells infected with wild-type B. abortus [47]. Also
in the murine system, B. abortus-induced secretion of IL-12p40 by
bone marrow-derived DCs depended on TLR2 [37]. Notably,
another study revealed that B. abortus-induced secretion of IL-
12p40 in murine splenic DCs was independent of TLR2 [48], and
TLR2 knockout mice were able to control B. abortus infection
similar as wild-type animals indicating that pathogen-recognition
through TLR2 is not essential for resistance to B. abortus in the
murine brucellosis model [49,50]. Our data regarding the
involvement of TLR6 (together with TLR2) in the cellular
recognition of B. abortus is supported by a recent study by de
Almeida et al. [51] who also showed that TLR6 cooperates with
TLR2 in sensing B. abortus strain 2308. In addition, the authors
reported that TLR6 (but not TLR2) is required for the in vivo
control of the bacteria in the murine model of brucellosis, and that
murine DCs lacking TLR2 or TLR6 are unable to produce of
TNF-a or IL-12 [51].
In contrast, Zwerdling et al. [27] showed that cytokine
production of human DCs incubated with heat-killed wild-type
strain 2308 depends on both TLR2 and TLR4. Similarly, both
receptors are involved in S19-induced TNF-a production by
murine macrophages but dispensable for the clearance of strain
S19 following intraperitoneal infection of mice [50]. In contrast,
TLR4 knockout mice showed significantly higher bacterial burden
than control animals after infection with strain 2308 [49], and the
Brucella lumazine synthase [52], or the protein moiety of Omp16
[53], or both, rather than Brucella LPS, are putative ligands in
TLR4-mediated protection against B. abortus. These inconsistent
results may be due to distinct experimental approaches, particu-
larly, the different cell types used as reporter systems.
DCs incubated with B. abortus S19 secreted substantial amounts
of IL-12p70 although the opposite is characteristic for cells
stimulated only through TLR2 [54]. Thus, the involvement of an
additional receptor in DC-activation is likely, and synergistic
effects of, e.g., distinct TLR ligands on IL-12 production have
been reported [55].
Where as other TLRs expressed by human DCs, such as TLR5
or TLR3 and TLR8 are unlikely involved in DC-activation by
brucellae, which lack flagella, dsRNA, and ssRNA, other innate
receptors, such as the cytosolic nucleotide oligomerization domain
(NOD) receptors (B. abortus localizes intracellularly) might
Figure 9. B. abortus strain S19 induces NF-kB activation in
HEK293 cells overexpressing TLR2. HEK293 cells were transiently
transfected with human TLR2. After stimulation with the diacyleted
lipopeptide Pam2Cys or heat-inactivated B. abortus S19, NF-kB
activation was assessed by a reporter gene assay (A), and IL-8 release
by ELISA (B). Cells not transfected with TLR2 failed to exhibit NF-kB
activation (not shown). Measurements were performed in triplicates,
shown are mean values 6 SD. One representative experiment out of
two is shown.
doi:10.1371/journal.pone.0065934.g009
Figure 10. Both B. abortus S19 and strain 2308 induce IL-8
secretion by HEK293 cells overexpressing TLR2 but not TLR4.
HEK293 cells were transiently transfected with human TLR2 (A) or TLR4
(B). After stimulation with LPS (rough, LPS Re595; smooth, LPS EH100) or
heat-inactivated B. abortus S19 or strain 2308, NF-kB activation was
assessed by IL-8 release by ELISA. Measurements were performed in
triplicates, shown are mean values 6 SD. One representative
experiment out of two is shown.
doi:10.1371/journal.pone.0065934.g010
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contribute to this process. Although Oliveira et al. [56] have
recently shown that NOD1 or NOD2 knockout mice were equally
susceptible to infection with the S2308 strain as wild-type animals,
this does not exclude the contribution of one of these receptors in
DC-activation since similar data have been reported for myco-
bacterial infections. In experimental tuberculosis, NOD knockout
mice were similarly susceptible to M. tuberculosis infection while
NOD-deficient DCs produced less IL-12 as well as IL-6 and IL-10
upon stimulation with mycolylarabinogalactan peptidoglycan [57].
Whether non-leukocytes, e.g., endothelial cells that produce pro-
inflammatory cytokines in response to the infection with B. abortus
in vitro [58], contribute to the induction of specific immune
responses in vivo needs to be determined. Other receptors possibly
involved in S19-induced DC-activation comprise cytosolic recep-
tors recognizing bacterial nucleic acids, e.g., those of the Rig-I like
receptor (RLR) family, or other yet undefined DNA sensor
receptors [35].
In conclusion, B. abortus S19 infects and activates human DCs
without causing apparent cytotoxicity, and TLR2 is involved in
the recognition of the bacteria. Since the genome of S19 has
recently been analyzed [59], the inactivation of genes encoding
defined virulence factors will yield further attenuated strains on the
background of B. abortus S19. Our data encourage future work,
e.g., in vivo studies in non-human primates, regarding the use of
such bacteria as vaccine vectors for the induction of Th1 immune
responses.
Supporting Information
Figure S1 Expression of DC maturation markers by
DCs upon infection with B. abortus S19 and cultured in
the presence of pro-inflammatory cytokines. Monocyte-
derived immature DCs were infected with B. abortus S19 (MOI, 20)
for 1 h, the bacteria were washed out, and the cells incubated in
the presence of pro-inflammatory cytokines (TNF-a, IL-1b, IL-6,
PGE2). Uninfected control cells were incubated alongside in the
presence or absence of cytokines. After 48 h, the phenotype of the
cells was determined by flow cytometry. Medians of the MFIs as
well as the 25% and 75% percentiles of the MFIs of six
independent experiments (MFIs of isotype controls were subtract-
ed). * p,0.05 compared to untreated DCs (Wilcoxon matched-
pairs signed rank test).
(TIFF)
Figure S2 Expression of DC maturation markers by B.
abortus S19-infected DCs. Monocyte-derived immature DCs
were infected with B. abortus S19 (MOI, 20) for 1 h, the bacteria
were washed out, and the cells were incubated for another 48 h.
Control cells were left uninfected. After 48 h, the phenotype of the
cells was determined by flow cytometry. Medians of the MFIs as
well as the 25% and 75% percentiles of the MFIs of six
independent experiments (MFIs of isotype controls were subtract-
ed). * p,0.05 compared to untreated DCs (Wilcoxon matched-
pairs signed rank test).
(TIFF)
Figure S3 Expression of DC maturation markers by
DCs incubated with heat-inactivated B. abortus strain
S19. Immature DCs were incubated in the presence of heat-
inactivated B. abortus S19 (equivalent to MOI 10) or kept in GM-
CSF and IL-4 as immature cells. After 48 h, the phenotype of the
cells was characterized by flow cytometry. Medians of the MFIs as
well as the 25% and 75% percentiles of the MFIs of six
independent experiments (MFIs of isotype controls were subtract-
ed). * p,0.05 compared to untreated DCs (Wilcoxon matched-
pairs signed rank test).
(TIFF)
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